In addition to targeting E-cadherin, Hakai reportedly promotes breast cancer cell proliferation in an E-cadherin independent manner [35], and elevated in human colon and gastric adenocarcinomas [35–37]. Here, CDH1 is linked to gastric adenocarcinoma.